Compare OCCI & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCCI | SEER |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.4M | 97.3M |
| IPO Year | N/A | 2020 |
| Metric | OCCI | SEER |
|---|---|---|
| Price | $3.16 | $1.73 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 228.1K | 208.9K |
| Earning Date | 12-11-2023 | 05-13-2026 |
| Dividend Yield | ★ 24.32% | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $16,578,000.00 |
| Revenue This Year | N/A | $2.14 |
| Revenue Next Year | $10.19 | $25.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $2.62 | $1.65 |
| 52 Week High | $6.43 | $2.41 |
| Indicator | OCCI | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 38.10 |
| Support Level | $2.80 | $1.69 |
| Resistance Level | $4.97 | $1.96 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 6.90 | 21.23 |
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.